Lipopeptides activate G,-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells
Jan F. KLINKER, Ariane HOER, Ingo SCHWANER, Stefan OFFERMANNS, Katharina WENZEL-SEIFERT and Roland SEIFERT*
Institutfur Pharmakologie, Freie Universitat Berlin, Thielallee 69-73, D-14195 Berlin, Federal Republic of Germany
Synthetic lipopeptides activatesuperoxide-anion (02-) formation in human neutrophils in a pertussis-toxin (PTX)-sensitive manner, suggesting the involvement of G-proteins of the
G,
family in the signal-transduction pathway. We compared G- protein activation by lipopeptides and the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine (fMLP) in dibutyryl- cyclic-AMP-differentiated HL-60 cells. Thelipopeptide (2S)-2- palmitoylamino-6-palmitoyloxymethyl-7-palmitoyloxyhepta- noyl-SK4 (Pam3AhhSK4) and fMLP activated high-affinity GTPase, i.e. the enzymic activity of G-protein a-subunits, in HL- 60 membranes in a time- and protein-dependent manner, but they had no effect on Mg2+-ATPase and Na+/K+-ATPase.
Pam3AhhSK4 and fMLP increased
Vmax
of GTP hydrolysis.Pam3AhhSK4 activated GTP hydrolysis with half-maximal and maximal effects at about
2,uM
and 10,uM respectively. Other lipopeptides activated GTPhydrolysis as well. Lipopeptides were less effective than fMLP toactivate GTPase. In membranes from PTX-treated cells, the stimulatory effects of lipopeptides andINTRODUCTION
Human neutrophils play an important role in host defence against bacterial infections and are activated by the bacterial chemotacticpeptide fMLP (for review see Rossi, 1986; Seifert andSchultz, 1991). fMLP, after bindingto specific heptahelical membrane receptors, activates the PTX-sensitive G-proteins,Gi2 and
G,3
(Gierschik etal., 1989; Offermanns et al., 1990). Thisprocess leads to the activation of phospholipase C and ofnon-
selective cation channels (resulting inanincrease in[Ca2+] ) and ofphospholipaseD(resulting in PA formation) (Paietal., 1988;
Bauldry etal., 1991; Kessels et al., 1991; Seifert etal., 1992a;
Krautwurst et al., 1992). Stimulation by fMLP of neutrophils and differentiated HL-60 leukaemic cells cumulates in the ac-
tivation of the 02-forming NADPH oxidase (for review see
Rossi, 1986; Seifert and Schultz, 1991).
The outercell wall ofGram-negative bacteria contains lipo- protein (for review seeBraun, 1975). Lipoprotein and synthetic lipopeptides are effective activators of B-lymphocytes (Resch andBessler, 1981; Bessleretal., 1985). We have shown recently thatlipopeptides activate02-formation in humanneutrophils in
a PTX-sensitive manner, suggesting the involvement of
G,-
proteins in thesignal-transduction pathway (Seifertetal., 1990).
As there isnoknownheptahelicalreceptorforlipopeptides,and
as only lipopeptides bearing positive charges activate 02-
fMLP on GTPase were abolished. InN-ethylmaleimide-treated membranes, the relative stimulatory effect ofPam3AhhSK4 on GTP hydrolysis was enhanced, whereas that of fMLP was diminished. fMLP and Pam3AhhSK4 activated GTPase in an over-additive manner in N-ethylmaleimide-treated membranes.
UnlikefMLP, Pam3AhhSK4 did not enhanceincorporationof GTP azidoanilide into, and cholera-toxin-catalysed ADP-ribo- sylation of
G,-protein
oc-subunits in,HL-60membranes and did not induce rises in cytosolicCa2+ concentration. Pam3AhhSK4 and fMLP stimulated phosphatidic acid formation in a PTX- sensitive manner. Pam3AhhSK4 itself did *not activate 02- formation, but potentiatedthestimulatory effects offMLP. Our data suggest that (i) lipopeptides activate the GTPase ofG,-
proteins, (ii) lipopeptides and fMLP activate
Gi-proteins
differently, (iii) lipopeptides stimulate phospholipaseD viaG,-
proteins, and (iv)phosphatidic acid formation is not sufficient foractivationof
02-
formation.formation, we put forward the hypothesis that lipopeptides activate
Ga-proteins
directly, i.e. in a manner similar to thatof othercationic-amphiphilicpeptidessuch as substance Pand the wasp venom mastoparan(Higashijimaetal., 1988,1990;Mousli etal., 1990; Seifertetal., 1990; Tomita etal., 1991).However, the cationic-amphiphilic lipopeptides Pam3CSK4 and Pam3AdhSK4donot stimulateGTPhydrolysis by G-proteinsin HL-60membranes(Seifertetal., 1992b).Additionally,wehave shown that lipopeptides, i.e. Pam3CSK4 and Pam3AhhSK4, activate tyrosine phosphorylation in Bt2cAMP-differentiated HL-60cells(Offermannsetal., 1992). The latter findingprompted ustoexamine theeffects ofPam3AhhSK4onG-protein activation in membranes fromBt2cAMP-differentiated HL-60cells and to studyitseffects on[Ca2+]1,
PAformation and02- formation in thesecells.MATERIALS
ANDMETHODS Materials
The lipopeptides Pam3AhhSK4 Pam3CSK4RPQASGVYMGN- LTAQ and Pam3CSK4RPQASVYMNLTAQ were kindly pro- videdby Dr. J. Metzger,Dr.K.-H.WiesmiullerandDr.G.Jung, Institut fur Organische Chemie der Universitiit
Tiibingen,
Germany. Thelipopeptide Pam3CSK4YGGFLwaskindly
pro- videdbyDr.C.Sakarellos,DepartmentofChemistry, University
Abbreviations used: Bt2cAMP, dibutyryl cAMP;
[Ca2+]i,
cytosolic Ca2+ concentration; CTX, cholera toxin; G,-proteins, family of highly similar G-proteins(Gil-G3);
fMLP, N-formyl-L-methionyl-L-leucyl-L-phenylalanine; NEM, N-ethylmaleimide; 02-, superoxide anion; PA, phosphatidic acid, Pam3, N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]; Pam3Adh, (2S)-palmitoylamino-6,7-bis(palmitoyloxy)heptanoyl; Pam3Ahh, (2S)-palmitoyl- amino-6-palmitoyloxymethyl-7-palmitoyloxyheptanoyl; PTX,pertussistoxin.PeptidechainslinkedtoPam3, Pam3Adhand Pam3Ahharegiven in the one-letter code.* To whomcorrespondence shouldbeaddressed.
3-phosphocholine (60Ci/mmol) was from Dupont/New Eng- land Nuclear (Bad Homburg, Germany). NEM was from Sigma Chemie (Deisenhofen,Germany).Stocksolutionsoflipopeptides (1 mM each) anddilutions were prepared in distilled water and storedat -20 'C.Sources ofothermaterials havebeendescribed elsewhere (Ebel et al., 1976; Rosenthal et al., 1986; Seifert and Schultz, 1987; Seifertet al., 1990, 1992a,b; Offermanns et al., 1990, 1991; Krautwurst et al., 1992; Wenzel-Seifert and Seifert, 1993).
Cell culture and membrane preparatlon
HL-60 cells were grown in suspension culture at 37 'C and were differentiatedtowards neutrophil-like cells with Bt2cAMP (0.2 mM) for48 h(Wenzel-Seifert andSeifert, 1993). For deter- mination of the activities ofhigh-affinity GTPase,Mg2+-ATPase and Na+/K+-ATPase, andforphotolabelling, HL-60 membranes wereprepared asdescribed bySeifertand Schultz (1987). PTX (100ng/ml) or itscarrier (control) was added to cell cultures 24h before measurement of PAformation ormembrane prep- aration. Under theseconditions, more than 95 % of
G,-protein
a-subunits wereADP-ribosylated (results not shown).
GTPase assay
GTPhydrolysiswasdetermined as describedbyWenzel-Seifert and Seifert (1993). Reaction mixtures (100,d) contained membranes from Bt2cAMP-differentiated HL-60 cells (3.0- 7.0,ug of protein/tube), 0.5
1sM
[y-32P]GTP (0.1,Ci/tube), 0.5 mMMgCl2, 0.1mMEGTA, 0.1mMATP, 1 mMadenosine5'-[Ly-imido]triphosphate,
5 mMphosphocreatine,
40jug
of creatine kinase, 1mM dithiothreitol and 0.2% (w/v) BSA in 50 mMtriethanolamine/HCl,
pH 7.4. Reaction mixtures con- tained substances at various concentrations and were pre- incubated for3min at 25'C.Reactionswereinitiated byaddition of[y-32P]GTP
andwereconductedfor 10-20min, unlessstated otherwise.Low-affinity
GTPaseactivity was determined in the presenceof50,sM
GTP and amountedto < 5%oftotalGTPase activity.Treatment of HL-60 membranes
with NEMHL-60 membranes were treated with NEM as described by McLeish et al., (1989) with modifications. Briefly, membranes (5.0,Cg of protein/tube) were incubated for 10min in reaction mixtures containing0.1 mM NEMorsolvent(control), 0.5,uM
[y-32P]GTP
(0.1sCi/tube),
0.5 mM MgCl2, 0.1mM EGTA, 0.1 mM ATP, 1 mM adenosine5'-[fi,y-imido]triphosphate,
5 mMphosphocreatine,40
,ug
of creatine kinase and 0.2 % BSA in 50 mMtriethanolamine/HCl,
pH 7.4.Thereafter, dithiothrei- tol (5mM) was added, and reaction mixtures were incubated forafurther10min.The membraneswerethen usedimmediately
forthe GTPaseassay.Mg -ATPase and Na+/K+-ATPase assays
Theactivities of
Mg2+-ATPase
andNa+/K+-ATPase
in HL-60 membranesweredetermined as described by Ebeletal. (1976).determined asdescribedbyAmes(1966).
Assay for photolabelling of membrane proteins
HL-60membranes
(50,Cg
of protein in60,ul)wereincubatedat 30°C in a buffer consisting of0.1 mM EDTA, 5 mM MgCl2,1mM benzamidine, 10 ,M GDP and 30 mM Hepes/NaOH, pH7.4. After exposure to various substances, samples were
incubated foranother 3 min with10nM[a-32P]GTP azidoanilide (1 uCi/tube). Stopping of reactions and irradiation of samples
wereperformed asdescribedbyOffermannset al.(1990).
Assay
forCTX-catalysed ADP-ribosylatIon of
membrane proteins HL-60 cellswerehomogenized by 20passesthrougha26-gauge needle in a buffer consisting of 150 mM NaCl, 3 mM MgCl2,1 mM EDTA, 1 mM dithiothreitol and 20 mM Hepes/NaOH, pH 7.4. After centrifugation at 1000g for 10min at 4°C, the supernatantsuspensionwasincubated for 60 minat30°C in the above buffer supplemented with 1mM guanosine
5'-[/Jy- imido]triphosphate.
Thereafter, the suspensionwas centrifuged at 30000g for 15min at 4 'C. The pellet, referred to asmembranes, wasdissolved in abuffercontaining 1 mMEDTA and 10 mM Tris/HCl, pH 7.4. CTX was activated by mixing toxin stock solution (2mg/ml) withanequal volume of 40 mM dithiothreitol and subsequent incubation for 10 min at 30'C.
Reaction mixtures (50 ul) contained 3 ,iM [32P]NAD'
(5,c1Ci/
tube), 3 mM MgCl2, 1mM ATP, 10mM thymidine, 0.2 % BSA, 2 ,g of activated CTX and 0.1 M potassium phosphate, pH7.4, and various substances. After preincubation for 3 min, reactionswere initiated by addition of membranes from about
1 x107 HL-60 cells. After incubation for 60 min at 30°C, reactionswereterminatedby addition of 20 mMHepes/NaOH, pH 7.4 (4'C),andcentrifugationat12000gfor10minat4'C.
Assay
for PA formationPAformationwasdetermined asdescribedby Paiet al. (1988) andBourgoin and Grinstein (1992), with modifications. In brief, HL-60 cells were centrifuged at 250gfor 10minat 20'C and
were suspended at 1 x106 cells/ml in a buffer consisting of 125 mMNaCl, 0.7 mM MgCl2, 0.5 mMEGTA, 10 mM glucose, 0.1% fatty-acid-free BSA and 25mM Hepes/NaOH, pH 7.2.
Centrifugation was repeated. HL-60 cells were suspended at 2x107 cells/ml in the above buffer and incubated for 90 minat 37'C in the presence of 10-15 fiCi/ml 1-0-[3H]hexadecyl-2- acetyl-sn-glycero-3-phosphocholine. Thereafter, cells were di- lutedto 1 x106cells/ml in the above buffer andwerecentrifuged at250gfor 10minat20'C. HL-60 cells[(0.5-1.0)x10"cellsin
100
fil]
were incubated for 6min at 37'C in the presence of1 mMCaCl2 and1 fg/ml cytochalasin B. Cellswereexposedto solvent (control),
Pam3AhhSK4
(10 fiM) or fMLP (IfM) for 15min. Reactionswereterminatedby the addition of 500,l of CHCl3/CH3OH/conc. HCl (400:200:1, by vol.). Phase sep-arationwasachievedby additionof 250,ulofwaterand 150flof CHC13. The sampleswerecentrifuged at 12000gfor 10minat 4'C. The upperphasewasremoved, and 400,ulof the organic phasewas dried undernitrogenat 30'C. Lipidsweredissolved in 50jl of
CHC13
and spotted on t.l.c. plates (Whatman LK 6 D). Non-radioactive lipid standards were added, and the plates were developed in a solvent system consisting of CHCl3/CH3OH/acetic acid (13:3:3, by vol). Lipid standards Reaction mixtures(100 ,1d)
contained6.0,ug
ofprotein
and were detectedby
exposure to iodine vapour, and the areas1200
E
0E
C1
.aa) 0 I- 0
10 15 20 25 30 0 2 4 6 8 10
lime(min) Protein(i/tube)
E 300 0 ._n 0
200 I- 100
Fire1 Time-andprotein-dependenceof
high-affinity
GTPhydrolyski InmembranesfromBt2cAMP-dlfferentlated HL-60cells
High-affinity GTP hydrolysiswasdetermined as described in the Materials and methods sectioninthe presenceofPam3AhhSK4 (10jiM)(*),fMLP(10jiM)(-),orwateradded instead of stimulus (control) (-). (a) GTPhydrolysisas afunction of time. Reactionswereconducted for the indicatedperiodsof time. Reaction mixtures contained 5.7 g ofprotein (mainpanel)and 6.2jigof protein (inset). (b) GTP hydrolysisasafunction of theamountofprotein. Reaction mixtures contained the indicatedamountsofprotein,and reactionswereconducted for 15 min.
The open circlesindicate that at the designated incubation time and amount of protein no GTP was hydrolysed. Thestimulatory effects ofPam3AhhSK4onGTPhydrolysisweresignificantversus control (P<0.05,Wilcoxontest) under allconditions studied.
corresponding to PA were scraped off after sublimation of iodine. Lipids were eluted from the silica gel with 1 M HC1/CH30H(1/1,v/v), andradioactivitywasdetermined ina liquid-scintillation counter.
Assay for 02- formatlon
2- formationwasmonitoredat550nm
by
continuousmeasure- ment offerricytochrome c reduction inhibitableby superoxide
dismutase,by usinganUvikon810dual-beamspectrophotometer
(Kontron, Eching, Germany) (Seifert etal.,
1990). Bt2cAMP- differentiatedHL-60cells(2.5x106cells in 500,ul)
wereincubated for 3min at 37°C before addition of stimuli. The absolute amountsof 2-generatedwithin 10 min were calculated.Miscellaneous
Proteinwas determined
by
the method ofLowry
etal.(1951).
[y-32P]GTP
was preparedasdescribedby
Walsethetal.(1991).
[c_-32P]GTP
azidoanilide wasprepared
as describedby
Offermannsetal.(1991). [32P]NAD
wassynthesized
asdescribed by Cassel and Pfeuffer(1978).SDS/PAGE
andautoradiography
wereperformedas described
by
Rosenthal etal.(1986). [Ca2+]J
wasdetermined
by using
thefluorescentdye fura-2,
asdescribed by Seifertetal.(1992a).
Data
reproducibility
Datashown inFigures 1-3and 5 and Tables 1-3are themeans of assay
quadruplicates.
Unlessshown,
the S.D. values weregenerally less than 5%
(GTP hydrolysis)
and10% (02-
formation) ofthemeans. Similar results were obtainedwith at least threedifferentpreparations
ofHL-60membranesorintact HL-60 cells. Basal GTPhydrolysis
and the extent of GTPase stimulation causedby
fMLP andPam3AhhSK4 (10 j/M each)
varied to some extentamong different membranepreparations
fromBt2cAMP-differentiated
HL-60cells(see Figures
1-3 and Tables 1and2).
Similarfindings
have beendocumented forbasal and fMLP-stimulated GTPhydrolysis
in membranes from dimethylsulphoxide-differentiated
HL-60cells(McLeish
etal.,
1989). Theautoradiographsshownin Figure 4 are representative of at least threeindependentexperiments.
RESULTS
First, the time- and protein-dependence ofhigh-affinity GTP hydrolysisinHL-60 membranes was studied. In the presence of 5.7jig of protein per tube, Pam3AhhSK4 and fMLP (10 ,M each) stimulated GTP hydrolysis in a linear manner for up to 30min(Figure 1).Activation ofGTPase by thelipopeptideand fMLPoccurred withoutmeasurable delay (see Figure la, inset).
At anincubation time of15 min,basal, lipopeptide- and fMLP- stimulated GTP hydrolyseswerelinear up to 10jigofprotein per tube.
Figure 2 shows typical Lineweaver-Burk plots of basal, Pam3AhhSK4-andfMLP-stimulatedGTPhydrolyses in HL-60 membranes. TheKmofbasal high-affinity GTPase in HL-60 mem- branes was 0.45+0.12,M (mean+S.D., n=6). This value corresponds to the Km ofhigh-affinity GTPase in human and rabbitneutrophil membranes(Feltner et al., 1986; Kupper et al., 1992). Thelipopeptide and the formyl-peptideincreased
VmJ..
ofGTPhydrolysis in HL-60membranes withoutaffecting
K,.
Theinfluence of
Pam.AhhSK4and
fMLP onMg2+-ATPaseand Na+/K+-ATPase wasstudied.Theactivities of these enzymes in HL-60 membranes were 0.26 + 0.06 and 0.15 + 0.02j#mol/min
permg
respectively.
Pam3AhhSK4 and fMLP(10,M each) did notalter theseenzymeactivities (results not shown).Concentration/responsecurvesfor the stimulatory effectsof Pam3AhhSK4 and fMLP on high-affinity GTPase in HL-60 membranes are shown inFigure3.
Pam.AhhSK4
activated GTP hydrolysis with anEC50
of about 2,M and a maximum at10,uM.
fMLP activated GTPase with anEC50
of 0.5jiM
and a plateau at 30-100I M. The effectiveness of Pam3AhhSK4 (100 ,M)to activateGTPase was about 30 % of that of fMLP (100jiM).Theeffectsoffourlipopeptides(10
jiM
each)on GTPhydro-lysis
were compared (see Figure 3, inset). Pam3CSK4RPQA-SGVYMGNLTAQ
contains theepitope of lymphocytic chorio- meningitisvirusnucleoprotein, RPQASGVYMGNLTAQ, used for induction ofcytotoxicT-lymphocytes
in vivo(Schulzet al.,Treatments with carrier(control) and PTX were performed as described in the Materials and methods section. High-affinity GTPase activity in HL-60 membranes was determined as described in the Materials and methods section. For determination of basal GTP hydrolysis, water(solvent) was added instead of stimulus.
GTPhydrolysis (pmol/min per mg)
Stimulus Control PTX
Water(solvent) fMLP(10 ,uM) Pam3AhhSK4(10 1sM)
26.0 + 0.5 61.4 +2.1 35.2 +1.0
15.4+0.7 14.8 + 0.5 15.5+0.6
Figure 2 KInetIc analysis of hgh-affinity GTP hydrolysis in membranes from Bt2cAMP-dNfferentlated HL-60 cells
GTPhydrolysiswasdeterminedasdescribedintheMaterials andmethods section with GTP (0.07-1.0 1sM)inthepresenceofPam3AhhSK4(10,PM)(*),fMLP(10 ,uM) (M),orwater addedinstead ofstimulus(control) (M). Lineweaver-Burk plotsoftypical experimentsare shown. Thestimulatory effectsof Pam3AhhSK4on GTP hydrolysisweresignificant versus control (P<0.05,Wilcoxontest)underallconditionsstudied.
15 -
E~ 9-
13-
,~ ~ ~ ~~0_ I I-*I E
.Co 11 -o
CL~ ~ ~ ~ ~
0.001 0.01 0.1 1 10 100
[Substance](pM)
Figure 3 ConcentratIon/respons curvesfor effects of Pam,AhhSK and fMLP on high-affinity GTP hydrolysis In membranes from Bt24MP- dMifrentiated HL-60 elis: comparlsonof effctsofvariousllpopeptides High-affinityGTPaseactivityinHL-60 membraneswasdeterminedasdescribed in the Materials andmethods section. Main panel:effects ofPam3AhhSK4 (*)and fMLP(U)atvarious concentrations on GTP hydrolysis. Inset shows effects of various lipopeptides (101sM each) on GTP hydrolysis: Pam3AhhSK4 (LP1), Pam3CSK4RPOASVYMNLTAQ (LP2), Pam3CSK4RPQASGVYMGNLTAQ (LP3), Pam3CSK4YGGFL (LP4).
1991). The peptide RPQASVYMNLTAQ, contained in Pam3CSK4RPQASVYMNLTAQ,lackstwoglycineresidues and
waspreparedascontrolsubstance for induction ofcytotoxicT- lymphocytes(Schulzetal., 1991). Pam3CSK4YGGFLcontains the Leu-enkephalin pentapeptide, YGGFL. Pam3CSK4RPQ-
ASGVYMGNLTAQ and
PamsCSK4RPQASVYMNLTAQ
Table 2 Effectof NEM onhigh-affinityGTPhydrolysisinmembranes from
Bt2cAMP-dlfferentiated
HL-60cells:interactIon
of PamAhhSK4 withfMLPTreatments with solvent (control) and NEM were performed as described in the Materials and methods section. High-affinity GTPase activity in HL-60 membranes was determined as described in the Materials and methods section. For determination of basal GTP hydrolysis, water(solvent) was added instead of stimulus.
GTPhydrolysis (pmol/min per mg)
Stimulus Control NEM
Water(solvent) fMLP(10,uM) Pam3AhhSK4 (10 1M) fMLP+Pam3AhhSK4
12.8+0.2 21.4 +0.8 17.0+0.5 23.3 +0.4
6.5+0.1 9.1 +0.2 9.5+0.2 13.3+0.4
weresimilarly effective as Pam3AhhSK4 to stimulate GTPase, whereasPam3CSK4YGGFLwasbyabout 50% less effective.
Table 1 compares theeffects ofPam3AhhSK4 and fMLP on
GTPhydrolysis in control membranes and in membranes from PTX-treated cells. In membranes from PTX-treated cells, the stimulatory effects offMLP andPam3AhhSK4onGTPhydrolysis
were abolished. Similarly to
Pam.AhhSK4.
PamCSK4RPQ-
ASGVYMGNLTAQ, Pam3CSK4RPQASVYMNLTAQ and Pam3CSK4YGGFL (10 uM each) had no effect on GTP hydrolysis in membranes from PTX-treated cells (results not shown).
NEM alkylates
G,-protein
a-subunits, thereby uncoupling receptors fromG-proteins ina mannersimilar to thatof PTX (Jakobsetal., 1982; McLeishetal., 1989). In control and NEM- treated membranes, fMLP stimulated GTPase by 67 % and 40% respectively (Table 2). The corresponding values for Pam3AhhSK4 were 33 % and 46 % respectively. In control membranes,Pam3AhhSK4andfMLPactivated GTPhydrolysis in a sub-additive manner (82% stimulation), and in NEM- treated membranesthey interacted inan over-additivemanner(105% stimulation).
In addition to the determination of GTP hydrolysis, photolabellingwith the reactive GTPanalogue GTP azidoanilide is an established method to assess activation ofG1-protein a-
subunitsbyformyl-peptidereceptors. Asreportedfor membranes fromdimethylsulphoxide-differentiatedHL-60cells(Offermanns et al., 1990), fMLP (10 M) increased incorporation of GTP azidoanilide into 40/41 kDa proteins, corresponding tothe a-
subunits of
Gi2
and GI3, in membranes from Bt2cAMP- differentiated HL-60 cells, but Pam3AhhSK4 (10 M) had nostimulatory effect (Figure 4).
7 0.20 E XI 0.15
.E
E 0.10 -0.05
3-
(a) (b)
2
. . #.. . .
0.1 1 10 100
[Lipopeptidel(pM)
43*
43010-~~~~~~~~~~~~~~* :.: :
3.*... ..o 30*;^
20 >
..
1 2 3
0.001 0.01 0.1
[fMLPI(WM)
Figure
5 Effects ofPam,AhhSK on02- formation In Bt2cAMP-dlfferentlated HL-60 cells: synergism with fMLP02-
formationwasdetermined asdescribed in the Materials and methods section. (a)Cells wereexposed toPam3AhhSK4atvariousconcentrationsinthe presence of fMLP(1,M) (U) orwater instead of fMLP(*).(b) CellswereexposedtofMLPatvariousconcentrations in thepresence of Pam3AhhSK4 (10FM)(*)orwaterinstead ofPam3AhhSK4 (-).Figure 4 Effects of
Pam3AhhSK4
and fMLP on incorporafon of GTPazidoanhlide
Into, and CTX-catalysed ADP-rlbosylation ofG,-proteln
ac- subunits Inmembranesfrom Bt2cAMP-dlfferentlated HL-60 cells (a) Photolabelling wasperformed as described in the Materials and methods section. The autoradiogram ofanSDSgelcontaining4Mureaand9%(w/v)acrylamideis shown.Lane 1, fMLP(101M); lane2,wateradded instead of stimulus (control); lane3, Pam3AhhSK4 (10,M).(b)ADP-ribosylationwasperformedasdescribed intheMaterials andmethods section.The autoradiogram of an SDS gel containing 10% (w/v) acrylamide is shown. Lane 1, Pam3AhhSK4 (10,M); lane 2, wateradded instead of stimulus (control); lane 3,fMLP (10
#M).
Numbersontheleftaremolecularmassesof markerproteins(kDa). DF,dyefront.Table 3 StUmulatlon by
Pam,AhhSK4
and fMLP of PA formaffon in Bt2cAMP-dlfferentlated HL-60cells:
effectofPTXTreatments with carrier(control) and PTXwereperformedasdescribed in the Materials and methods section. PAformation wasdetermined asdescribedin the Materials and methods section. The concentration of fMLPwas1,uM and that of Pam3AhhSK4was10,uM. For determination of basal PAformation,water(solvent)wasaddedinstead of stimulus.
PAformation (d.p.m.)
Stimulus Control PTX
Water(solvent fMLP Pam3AhhSK4
652+36 924+66 799+ 33
458 +6 492 +27 497+21
Moreover, CTX-catalysed ADP-ribosylation of
G,-protein
a- subunits was studied. By analogy to dimethyl sulphoxide- differentiatedHL-60cells (Gierschiket al.,1989), fMLP (10FM)
enhanced CTX-catalysed ADP-ribosylation ofG,-protein
a- subunits in membranes from Bt2cAMP-differentiated HL-60 cells(seeFigure 4).Unlike fMLP,Pam3AhhSK4
(10 uM) did not enhance ADP-ribosylation ofG,-protein
a-subunits.We investigated the effects of
Pam3AhhSK4
on[Ca2+]1
inBt2cAMP-differentiated
HL-60 cells. The lipopeptide (0.3- 10FM)
did notinducerises in[Ca2+]1
in HL-60 cells (results not shown). By contrast, fMLP potently and effectively increases[Ca2+1]
in Bt2cAMP-differentiated HL-60 cells (Seifert et al., 1992a,b).The effects of
lipopeptides
and fMLP on PA formationare shown in Table 3.Pam3AhhSK4 (10
M) andfMLP (1 FM)
increased PAformation by 23 % and 42 %respectively. InPTX- treatedcells, thestimulatory effects of Pam3AhhSK4 and fMLP onPA formation were greatly diminished. In the presence of ethanol (0.5 %, v/v),Pam3AhhSK4 (10
FM)
and fMLP(1 FM) stimulatedphosphatidylethanol formation to a similar extent as PAformation(results not shown).Regulation bylipopeptidesof02-formation in HL-60 cells is depicted inFigure5. Pam3AhhSK4itselfup to 100
FM
did not activate02-formation.However,Pam3AhhSK4 potentiatedO2
formationinducedby fMLP (1FM)with an
EC50
ofabout 2FM
and a maximum at 10
FM.
fMLPactivated02-formation with anEC50
of 15 nM and a maximum at 100 nM. Pam3AhhSK4 (10FM) substantially enhanced the effect of fMLP at sub- maximally andmaximally effective concentrations.DISCUSSION
Lipopeptides activate 02- formationinhuman neutrophils in a PTX-sensitivemanner,suggestingtheinvolvementofG1-proteins in thesignal-transduction pathway (Seifertetal., 1990). Sofar, however, a heptahelical receptor for lipopeptides has not yet been identified. In addition, lipopeptides, unlike chemo- attractants, do not induce rises in
[Ca2+],
in HL-60 cells (Wenzel-SeifertandSeifert, 1993; Seifertetal., 1992a,b). Thusit is unlikely that lipopeptides activate Bt2cAMP-differentiated HL-60 cells through a chemoattractant receptor with known ligands orthrough thenewly clonedformyl-peptide-related re- ceptor with as-yet unknown ligands (Murphy et al., 1992).Thereforewehaveputforward thehypothesisthatlipopeptides activate G1-proteins directly, i.e. in a receptor-independent manner(Seifertetal., 1990).Thisassumptionissupportedbythe finding thatonly
lipopeptides
bearing positive chargesactivate 02- formation in human neutrophils (Seifert et al.,1990).
By analogytolipopeptides,thestimulatory effects ofvarious direct G-proteinactivators inneutrophilsareinhibited,
atleast inpart, by PTX (Serra et al., 1988; Perianin andSnyderman,
1989;Seifertetal., 1990, 1992b;Norgaueretal., 1992;Kanahoetal., 1992). To corroborate our
suggestion further,
we have now studiedtheeffects oflipopeptides
inBt2cAMP-differentiatedHL- 60cells,asthese cellsare auseful modelsystemfor theanalysis
ofGa-protein-mediated signal-transduction
processes at the940,,
670'
94 >, 670
-o
UE
0
'._E
C C 0
0
.:.9,...
....x..'..<..
30>
1 2 3
1
Wefound that the lipopeptide Pam3AhhSK4 activated high- affinity GTP hydrolysis in HL-60 membranes in a time-, membrane-protein- and stimulus-concentration-dependent manner(see Figures 1 and 3). Most importantly, the stimulatory effects of lipopeptidesonGTPase were inhibited by PTX, as were those of fMLP(seeTable 1). These data indicate thatlipopeptides increase the GTPase activity of
G1-proteins.
Pam3AhhSK4 increasedVm..
of GTP hydrolysis, suggesting that it stimulated the catalytic rate ofGTP turnover (see Figure 2). By analogy with lipopeptides, formyl-peptides also increaseVmJ-
of GTP hydrolysis (seeFigure 2) (Feltner etal., 1986). The stimulatory effect of Pam3AhhSK4 on high-affinity GTPase was not unspecific, inasmuchasthelipopeptide didnotaffect theactivities of othernucleotide-metabolizingenzymes,i.e.Mg2+-ATPase and Na+/K+-ATPase, inHL-60membranes.NEM, through alkylation of
G,-protein
a-subunits, disrupts the interaction ofheptahelical receptors with G-proteins in a manner similar to that of PTX-catalysed ADP-ribosylation (Jakobs et al., 1982; McLeish et al., 1989). With respect to the interaction of formyl-peptide receptors withG,-protein
a-subunits, alkylation and ADP-ribosylation have similar consequences, i.e they are inhibitory (see Tables 1 and 2) (McLeishetal., 1989). Concerning the interaction of lipopeptides with
G,-proteins,
ADP-ribosylation is alsoinhibitory(seeTable 1). Unexpectedly, alkylationwasfoundto enhance the relative extent oflipopeptide-stimulated GTP hydrolysis (see Table 2).These datasuggest thatalkylation and ADP-ribosylation ofa- subunits may affect G-protein function in different manners.
Alkylation of
G(-protein
a-subunits, unlike ADP-ribosylation, mayincrease theirlipophilicity, and therebymayfacilitate their interaction with lipophilic portions of lipopeptides. It is also possible that alkylation and ADP-ribosylation induce different conformations ofG,-protein
a-subunits, resulting in opposite effects concerning their interaction with lipopeptides, but not withregardtoreceptors.-Additionally, Pam3AhhSK4 and fMLP activated GTPasein NEM-treated membranesin a synergistic manner. Takentogether,these results suggestthatlipopeptides and formyl-peptides differently activate the GTPase ofG1-
proteins.Certainlipopeptides, i.e.
Pam3CSK4
andPam3AdhSK4,
donot stimulate GTP hydrolysis in membranes from Bt2cAMP- differentiatedHL-60cells(Seifertetal., 1992b).Itispossible that the extent of activation ofG,-proteins
induced by these lipopeptides is too small to be detected in the GTPase assay.Pam3CSK4,
Pam3AdhSK4 andPam.AhhSK4
have in common the positively charged peptide chain, but they differ in the structureof thelipid moiety (Seifertetal., 1992b). Withrespect toGTPhydrolysis, onlyPam.AhhSK4
isstimulatory (see Figure3) (Seifert
etal.,1992b).
Thesedifferential effects oflipopeptides
onGTPhydrolysissupportthe view that these substances donot activate the GTPase ofG,-proteins
in an unspecific manner.Intriguingly, the resultsofa recentstudy indicatethat
lipophilic
amino acids in the third cytoplasmic loop of heptahelical receptors may be moreimportant for G-protein activation than arepositively
charged amino acids (Cheung etal., 1992).
By analogy, the structure of the lipid moiety oflipopeptides
is important for their G-protein-activatingproperties
(seeFigure 3)
(Seifert et al., 1992b). However, the peptide chain is also of relevance for G-protein activation bylipopeptides.
This as-sumption
issupported by
thefindings
that thelipopeptides Pam3CSK4, Pam3CSK4RPQASGVYMGNLTAQ, Pam8CSK4-
RPQASVYMNLTAQandPam3CSK.YGGFLhaveincommon
The microbialalkaloidstaurosporine isa potentinhibitor of protein kinases, in particular of protein kinase C (Tamaokietal., 1986).Inaddition, staurosporine stimulates phospholipase D in rabbitneutrophils, presumablyvia directactivation of
Gi,
butit does not activate phospholipase C (Kanaho et al., 1992). By analogy, positively charged lipopeptides inhibit protein kinase C anddonotinduce rises in[Ca2+]i
inHL-60 cells (Bessler, 1990;Seifert et al., 1992b). These findings prompted us to study the effects of
Pam.AhhSK4
on phospholipase D in HL-60 cells. Pam3AhhSK4 activated the formation of PA and of phosphatidylethanol, a transphosphatidylation product specificallyformedby phospholipase D (see Table 3) (Paietal., 1988; BourgoinandGrinstein, 1992). Additionally, stimulation byPamkAhhSK4
of PAformationwasPTX-sensitive(see Table 3). These data indicate that the lipopeptide activates phospholipaseDviaG,-proteins.
In this context, the
question
arises whether the effects of Pam3AhhSK4on phospholipaseD weremediated via Gi2, Gi3or both Ga-proteins. Therefore we studied the effects of Pam3AhhSK4 on photolabelling and CTX-catalysed ADP- ribosylationof
G,-protein
a-subunitsinHL-60membranes. Both methods have been shown to be useful forthe analysis of G-protein activation by formyl-peptide receptors in membranes fromdimethyl sulphoxide-differentiated HL-60 cells (Gierschik et al., 1990; Offermanns et al., 1990). In agreement with the aforementionedstudies,wefoundprominent stimulatory effects of fMLP on photolabelling and CTX-catalysed ADP- ribosylation of Ga-protein a-subunits in membranes from Bt2cAMP-differentiated HL-60 cells (see Figure 4). However, Pam3AhhSK4 was devoid of any stimulatory effect in these regards.Thuswecannotyetanswerthequestionastowhich
G,-
protein subtypesareinvolved in theactivation ofphospholipase D by lipopeptides. Interestingly, some lipopeptides do not measurably stimulate theGTPase of
G,-proteins
(Seifert etal., 1992b). Moreover, even the most effective lipopeptides with regard to GTPase activation, i.e. Pam3AhhSK4, Pam3CSK4- RPQASGVYMGNLTAQand Pam3CSK4RPQASVYLMNLT- AQ,arestill muchlesseffective than fMLP(see Figure 3). Thus the sensitivityofphotolabellingand CTX-catalysed ADP-ribo- sylationmay betoolow todetect therelatively smallextentofGi-protein
activation by Pam3AhhSK4. However, itcannot be excluded that the lack ofstimulatory effect of lipopeptides onphotolabellingandCTX-catalysed ADP-ribosylation reflects also qualitative differences in activation of
G,-proteins
by these substances andby formyl-peptides (McLeishet al., 1989).The dataobtained withPam3AhhSK4 concerning stimulation of PAformationimplythatanincrease in[Ca2+]1 viaactivation ofphospholipaseCand/ornon-selectivecation channels isnot
aprerequisite forstimulation ofphospholipaseD(see Table 3) (Seifert et al., 1992b). In agreement therewith, Rosoff et al.
(1988), Bourgoinetal.(1990)and Kanahoetal.(1992) suggested thatphospholipase Dis activated in a Ca2+/phospholipase C- independentmanner. However, in human neutrophils, rises in [Ca2+]1 may play apart in the activation ofphospholipase D (Kessels etal., 1991; Bauldryet al., 1992).
The effectivenessofPam3AhhSK4 to activate PAformation
wasabout 50%of thatof fMLP(seeTable3). Nonetheless,the lipopeptideitself didnotactivate 2-formation(see Figure 5).
Thus stimulation ofphospholipase D is not sufficient for the activation of NADPH oxidase.Our dataareinagreementwith thoseobtainedbyKesselsetal.(1991)andBauldryet al.(1992).
By analogy to thecytokines, granulocyte/macrophage-colony- the
lipid portion,
but differ in thepeptide
chain and theirstimulating
factor andtumouir necrosisfactor-a,
activation ofPAformationby lipopeptidesmay beimportantforpotentiation of fMLP-induced 02- formation (see Table 3 and Figure 5) (Bourgoin etal., 1990; Bauldryetal., 1990).
In conclusion, we have shown thatlipopeptides activate the GTPase of G1-proteins and that lipopeptides and fMLP activate
G,-proteins
differently. Lipopeptides activate phospholipase D viaG,-proteins,
but PA formation is not sufficientforthe activationof02-formation.J.F. K.is a recipientofapredoctoralfellowship of the FreieUniversitat Berlin. We appreciatethesupplyoflipopeptides byDr.J.Metzger,Dr. K.-H.Wiesmullerand Dr.
G. Jung,Institut furOrganische ChemiederUniversitatTubingen,Germany,andby Dr. C.Sakarellos, Department of Chemistry, University of loannina, Greece.
Stimulatingdiscussions with Dr. J. Metzger, Dr. K.-H.Wiesmuller and Dr. G.Jung arealso acknowledged. We also thank Dr. G.Schultz, Institut fur Pharmakologie, Freie UniversitatBerlin,forhelpfuldiscussion. We aregratefultoMiss E. Bombien and Mrs. E. Glass for expert technical assistance. This work wassupported bygrants of the Deutsche Forschungsgemeinschaft.
REFERENCES
Ames, B. N.(1966) Methods Enzymol.8,115-118
Bauldry, S.A., Bass, D. A., Cousart, S. L. and McCall, C. E. (1991) J. Biol. Chem. 266, 4173-4179
Bauldry, S.A., Elsey, K.L. andBass, D. A.(1992) J. Biol. Chem.267, 25141-25152 Bessler, W. G. (1990)bga-Schriften 1, 196-204
Bessler,W.G., Cox, M., Lex, A., Suhr, B.,Wiesmuliler,K.-H.andJung, G. (1985) J. Immunol.135,1900-1905
Bourgoin, S. andGrinstein, S. (1992) J. Biol. Chem.267,11908-11916 Bourgoin,S., Plante, E., Gaudry, M., Naccache, P. H., Borgeat, P. and Poubelle,P.E.
(1990) J.Exp. Med. 172, 767-777
Braun, V.(1975) Biochim. Biophys. Acta415,335-377
Cassel, D. andPfeuffer,T.(1978) Proc. Natl. Acad. Sci. U.S.A. 75, 2669-2673 Cheung,A.H., Huang, R.-R. C. andStrader,C.D.(1992) Mol. Pharmacol. 41, 1061-1065 Ebel, H.,Aulbert,E. and Merker, H. J. (1976) Biochim. Biophys. Acta433,531-546 Feltner, D.E.,Smith, R. H. and Marasco,W. A.(1986) J. Immunol. 137, 1961-1970 Gierschik, P.,Sidiropoulos, D. and Jakobs,K.H.(1989)J.Biol. Chem.264, 21470-21473 Higashijima,T., Uzu, S., Nakajima, T. and Ross, E. M. (1988) J. Biol. Chem. 263,
6491-6494
Higashijima,T., Burnier, J. and Ross, E. M.(1990) J. Biol. Chem.265, 14176-14186 Jakobs, K.H., Lasch, P., Minuth, M.,Aktories,K.andSchultz,G.(1982) J. Biol. Chem.
257,2829-2833
Kanaho,Y., Takahashi, K.,Tomita,U., liri, T., Katada, T., Ui, M. and Nozawa, Y. (1992) J. Biol.Chem.267, 23554-23559
Kessels, G. C. R., Roos, D. and Verhoeven, A. J. (1991) J. Biol.Chem.266, 23152-23156 Krautwurst, D.,Seifert, R., Hescheler, J. and Schultz, G. (1992) Biochem. J. 288,
1025-1035
Kupper, R. W.,Dewald, B., Jakobs, K. H., Baggiolini, M. andGierschik, P. (1992) Biochem. J.282, 429-434
Lowry,0. H., Rosebrough, N. J., Farr,A.L.andRandall, R. J. (1951) J. Biol. Chem.193, 265-275
McLeish,K.R.,Gierschik, P., Schepers, T.,Sidiropoulos, D. and Jakobs,K.H. (1989) Biochem. J.260,427-434
Mousli, M.,Bronner, C., Landry, J.,Bockaert, J. and Rouot, B. (1990)FEBS Lett.259, 260-262
Murphy,P.M.,Ozcelik,T., Kenney, R. T.,Tiffany, H. L.,McDermott, D.and Franck, U.
(1992) J. Biol.Chem.267, 7637-7643
Norgauer,J., Eberle, M., Lemke, H.-D. andAktories, K. (1992) Biochem. J.282, 393-397 Offermanns, S., Schafer, R., Hoffman, B., Bombien, E., Spicher, K., Hinsch, K.-D.,Schultz,
G. andRosenthal,W. (1990)FEBS Left.260,14-18
Offermanns, S.,Schultz,G.andRosenthal, W. (1991) Methods Enzymol. 195,286-301 Offermanns, S.,Seifert,R., Metzger, J. W., Jung,G., Lieberknecht, A.,Schmidt, U. and
Schultz, G. (1992) Biochem. J.282, 551-557
Pai, J.-K.,Siegel, I.,Egan, R. W. and Billah, M. (1988) J. Biol. Chem. 263, 12472-12477 Perianin, A. andSnyderman, R. (1989) J. Immunol.143, 1669-1673
Resch,K.andBessler, W. (1981) Eur. J. Biochem. 115, 247-252
Rosenthal, W.,Koesling, D., Rudolph, U., Kleuss, C., Pallast, M., Yajima, M. and Schultz, G.(1986) Eur. J. Biochem.158, 255-263
Rossi, F. (1986) Biochim. Biophys. Acta853, 65-89
Rosoff, P. M.,Savage, N. and Dinarello, C.A.(1988)Cell 54, 73-81
Schulz, M.,Zinkernagel,R. M.andHengartner,H.(1991) Proc. Natl. Acad.Sci. U.S.A. 88, 991-993
Seifert, R. andSchultz, G.(1987) Biochem. Biophys. Res. Commun.146,1296-1302 Seifert, R. andSchultz,G.(1991) Rev. Physiol. Biochem. Pharmacol. 117,1-338 Seifert, R., Schultz,G.,Richter-Freund, M., Metzger, J.,WiesmUller, K.-H., Bessler, W. G.
and Hauschildt, S. (1990) Biochem. J.267, 795-802
Seifert, R., Hoer A.,Offermanns,S., Buschauer, A. and Schunack,W. (1992a) Mol. Pharmacol.42, 227-234
Seifert, R., Serke,S.,Huhn, D., Bessler, W. G., Hauschildt, S., Metzger, J., Wiesmuller, K.-H.andJung, G. (1992b). Eur. J. Biochem. 203,143-151
Serra, M. C., Bazzoni, F., Della Bianca, V., Grzeskowiak, M. and Rossi, F. (1988) J.Immunol. 141, 2118-2124
Tamaoki, T., Nomoto, H., Takahashi, I., Kato, Y., Morimoto,M.andTomita, F. (1986) Biochem.Biophys. Res. Commun. 135, 397-402
Tomita, U., Inanobe,A., Kobayashi, I.,Takahashi, K., Ui, M. and Katada,T.(1991) J.Biochem. (Tokyo) 109, 184-189
Walseth, T. F.,Yuen, P. S.T. and Moos, M. C. Jr. (1991) MethodsEnzymol. 195, 29-44 Wenzel-Seifert, K.and Seifert,R.(1993) J.Immunol.150, 4591-4599
Received 20May 1993/26 July 1993; accepted 30 July1993